GeneSegues is a biopharmaceutical company developing the next generation of targeted drugs for the treatment of cancer. We combine innovative RNAi therapeutics with novel sub-50 nanometer capsule technology that increases the amount of RNAi drug delivered to both primary and metastatic tumors.